Common Medications and Diabetic Macular Edema
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Common Medications and Diabetic Macular Edema
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Dr. Drew Carey interviews medical student Jawad Muayad and Dr. Sami S. Dahr on the impact of systemic medications, including glucagon-like peptide-1 receptor agonists, fenofibrates, thiazolidinediones, and calcium channel blockers, on the risk of developing diabetic macular edema in patients with type 2 diabetes mellitus. From their Ophthalmology Retina article, “Influence of Common Medications on Diabetic Macular Edema in Type 2 Diabetes Mellitus”
Influence of Common Medications on Diabetic Macular Edema in Type 2 Diabetes Mellitus. Muayad, Jawad et al. Ophthalmology Retina , Volume 9, Issue 6, 505 – 514
Sign up for the next Ophthalmology Journal Virtual Club on August 27, 2025, at https://store.aao.org/ophthalmology-virtual-journal-club.html
Imagine enjoying an unforgettable night with colleagues from around the world and other Ophthalmology Journal Podcast listeners in Orlando. Illuminate is the must-attend social event of AAO 2025, and you’re invited! Have drinks and heavy bites, listen to music and have fun on Oct. 18, while supporting ophthalmic education. Get your ticket when registering for AAO 2025 at aao.org/RegNow.